In-Depth Insights into the Monoclonal Antibodies In Veterinary Health Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Future CAGR is Anticipated for the Monoclonal Antibodies In Veterinary Health Market Over the 2025–2034 Period?
The market size for monoclonal antibodies in veterinary health has observed significant expansion in the recent past. It is predicted to escalate from $0.8 billion in 2024 to $0.92 billion in 2025 with an impressive compound annual growth rate (CAGR) of 15.2%. Factors contributing to this growth during the historical period include the global surge in pet ownership, the increase in chronic diseases among animals, the rise in pet adoption rates and heightened health awareness amongst pet owners.
Expectations are high for a swift expansion in the monoclonal antibodies in veterinary health market in the coming years. The market is predicted to reach $1.61 billion by 2029 with a compound annual growth rate (CAGR) of 15.0%. Factors contributing to this expected growth during the forecast period include an increased pet population, higher spending on pets, a surge in canine atopic dermatitis, a rising demand for more advanced veterinary healthcare, and an increased focus on animal health. The trends to look out for during the forecast period comprise advancements in biotechnology and research, progression in genetic engineering, pioneering treatments, advancements in therapies based on antibodies, and technological advancements in antibody engineering.
How Are the key drivers expanding the growth of the Monoclonal Antibodies In Veterinary Health Market?
The growth of the monoclonal antibodies in veterinary health market is anticipated to be driven by an increase in animal disease incidences. Intensified farming practices and climate change, which enhances the spread of disease vectors like ticks and mosquitoes, are causing a surge in animal diseases. Monoclonal antibodies offer precise and effective treatments as they focus on particular pathogens or proteins linked to disease processes, which makes them incredibly beneficial for treating animal diseases. For example, a report by the GOV.UK, a government website based in the UK, recorded in June 2024 that from April 2023 to March 2024, the amount of animals scrapped due to TB incidents escalated by 5% in England to 21,298, and by 17% in Wales to 11,197. These increasing animal disease incidences are propelling the growth of the monoclonal antibodies in veterinary health market.
Get Your Free Sample of the Global Monoclonal Antibodies In Veterinary Health Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20575&type=smp
Who Are the Influential Players Fueling Innovation and Growth in the Monoclonal Antibodies In Veterinary Health Market?
Major companies operating in the monoclonal antibodies in veterinary health market are:
• Sanofi S.A.
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc (GSK)
• Amgen Inc.
• Boehringer Ingelheim International GmbH
What Impact Are Industry Trends Having on the Monoclonal Antibodies In Veterinary Health Market’s Future Prospects?
Key players in the monoclonal antibodies in veterinary health market are prioritizing the creation of novel veterinary therapeutic solutions, like anti-NGF monoclonal antibody therapy, to handle chronic pain and inflammation in animals. This specific treatment is aimed at targeting and interrupting nerve growth factor (NGF) to alleviate pain and inflammation in animals dealing with enduring painful conditions. Take for example Zoetis, a U.S-based animal health company, which won FDA approvals in May 2023 for their products; Librela (bedinvetmab injection) and Apoquel Chewable. Librela, the first-of-its-kind monoclonal antibody therapy for managing pain related to osteoarthritis (OA) in dogs, is given through a monthly injection; while Apoquel Chewable is the first chewable drug specifically designed to control allergic itching and inflammation in dogs aged one year and above. Librela works by targeting and blocking NGF, thus preventing pain signals from reaching the brain and consequently reducing the dog’s pain perception. This represents a notable progression in veterinary pain management, introducing an innovative way of managing chronic pain in dogs.
Secure Your Global Monoclonal Antibodies In Veterinary Health Market Report Now for Fast and Efficient Delivery!
How Are the Key Segments of the Monoclonal Antibodies In Veterinary Health Market Impacting Its Expansion and Revenue Streams?
The monoclonal antibodies in veterinary health market covered in this report is segmented –
1) By Animal Type: Dogs, Other Animal Types
2) By Application: Dermatology, Pain, Other Applications
3) By End-User: Veterinary Hospitals, Other End-Users
Subsegments:
1) By Dogs: Canine Infectious Diseases, Canine Cancer Treatment, Canine Autoimmune Disorders, Canine Allergies
2) By Other Animal Types: Cats, Horses, Cattle, Swine, Poultry, Aquatic Animals, Small Mammals
What Regions Are Leading the Growth Trajectory of the Monoclonal Antibodies In Veterinary Health Market?
North America was the largest region in the monoclonal antibodies in veterinary health market in 2024. The regions covered in the monoclonal antibodies in veterinary health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Do Experts Define the Scope of the Monoclonal Antibodies In Veterinary Health Market?
Monoclonal antibodies in veterinary health are specialized proteins engineered to target and neutralize specific pathogens or toxins in animals, aiding in the diagnosis and treatment of various diseases. They are created by cloning a single type of immune cell to produce identical antibodies that precisely bind to their target.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Pain Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report
Veterinary Reference Laboratory Global Market Report 2025
Veterinary Radiosurgery System Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
